|
JPS6030654B2
(ja)
*
|
1980-12-31 |
1985-07-17 |
株式会社林原生物化学研究所 |
ヒトコロニ−刺激因子の製造方法
|
|
DE3110611A1
(de)
*
|
1981-03-18 |
1982-10-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen |
"mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
|
|
US4432751A
(en)
*
|
1982-03-05 |
1984-02-21 |
Baylor College Of Medicine |
Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction
|
|
JPS59137417A
(ja)
*
|
1983-01-28 |
1984-08-07 |
Morinaga Milk Ind Co Ltd |
人尿由来コロニ−形成刺激因子及びカリクレインの製造法
|
|
JPS61227526A
(ja)
*
|
1984-07-25 |
1986-10-09 |
Chugai Pharmaceut Co Ltd |
新規なコロニー刺激因子
|
|
UA29377C2
(uk)
*
|
1984-09-19 |
2000-11-15 |
Новартіс Аг |
Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
|
|
US4847201A
(en)
*
|
1985-02-05 |
1989-07-11 |
Cetus Corporation |
DNA encoding for CSF-1 and accompanying recombinant systems
|
|
US6146851A
(en)
*
|
1985-02-05 |
2000-11-14 |
Chiron Corporation |
DNA encoding NV2 (long form) and carboxy truncated fragments thereof
|
|
DE3689391T2
(de)
*
|
1985-02-05 |
1994-06-30 |
Cetus Oncology Corp., Emeryville, Calif. |
Rekombinanter koloniestimulierender faktor-1.
|
|
US6156300A
(en)
*
|
1985-02-05 |
2000-12-05 |
Chiron Corporation |
Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
|
|
US5104650A
(en)
*
|
1985-02-05 |
1992-04-14 |
Cetus Corporation |
Uses of recombinant colony stimulating factor-1
|
|
US5792450A
(en)
*
|
1985-02-05 |
1998-08-11 |
Chiron Corporation |
Purified human CSF-1
|
|
US5573930A
(en)
*
|
1985-02-05 |
1996-11-12 |
Cetus Oncology Corporation |
DNA encoding various forms of colony stimulating factor-1
|
|
US5556620A
(en)
*
|
1985-02-05 |
1996-09-17 |
Cetus Oncology Corporation |
Use of recombinant colony stimulating factor-1 to enhance wound healing
|
|
US5422105A
(en)
*
|
1985-02-05 |
1995-06-06 |
Cetus Oncology Corporation |
Use of recombinant colony stimulating factor 1
|
|
US5837229A
(en)
*
|
1985-02-05 |
1998-11-17 |
Chiron Corporation |
Uses of recombinant colony stimulating factor-1
|
|
JPH0753667B2
(ja)
*
|
1985-08-09 |
1995-06-07 |
新技術開発事業団 |
骨髄移植療法補助剤
|
|
US5078996A
(en)
*
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
|
US4721096A
(en)
*
|
1986-04-18 |
1988-01-26 |
Marrow-Tech Incorporated |
Process for replicating bone marrow in vitro and using the same
|
|
US5863531A
(en)
*
|
1986-04-18 |
1999-01-26 |
Advanced Tissue Sciences, Inc. |
In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
|
|
US5032508A
(en)
*
|
1988-09-08 |
1991-07-16 |
Marrow-Tech, Inc. |
Three-dimensional cell and tissue culture system
|
|
US5510254A
(en)
*
|
1986-04-18 |
1996-04-23 |
Advanced Tissue Sciences, Inc. |
Three dimensional cell and tissue culture system
|
|
US4963489A
(en)
*
|
1987-04-14 |
1990-10-16 |
Marrow-Tech, Inc. |
Three-dimensional cell and tissue culture system
|
|
US5160490A
(en)
*
|
1986-04-18 |
1992-11-03 |
Marrow-Tech Incorporated |
Three-dimensional cell and tissue culture apparatus
|
|
US5266480A
(en)
*
|
1986-04-18 |
1993-11-30 |
Advanced Tissue Sciences, Inc. |
Three-dimensional skin culture system
|
|
US5055291A
(en)
*
|
1986-11-04 |
1991-10-08 |
Baylor College Of Medicine |
Compositions for preventing secondary cataracts
|
|
US4871350A
(en)
*
|
1986-11-04 |
1989-10-03 |
Baylor College Of Medicine |
Methods and compositions for preventing secondary cataracts
|
|
JPS63245667A
(ja)
*
|
1987-03-31 |
1988-10-12 |
Ube Ind Ltd |
肥満細胞成長活性を有するヒトil−3産生ヒト細胞および肥満細胞成長活性を有するヒトil−3の製造方法
|
|
JP2831012B2
(ja)
*
|
1987-09-22 |
1998-12-02 |
カイロン コーポレイション |
組換えコロニー刺激因子‐1の使用
|
|
US5190876A
(en)
*
|
1988-12-27 |
1993-03-02 |
Emory University |
Method of modifying cellular differentiation and function and compositions therefor
|
|
RU2135191C1
(ru)
*
|
1990-04-24 |
1999-08-27 |
Ортек Интернэшнл, Инк. |
Композиционный эквивалент живой кожи, способ его получения, тест-набор
|
|
CA2363965C
(en)
|
1991-03-11 |
2010-05-18 |
Curis, Inc. |
Protein-induced morphogenesis
|
|
US5652337A
(en)
*
|
1991-03-11 |
1997-07-29 |
Creative Biomolecules, Inc. |
OP-3-induced morphogenesis
|
|
US6211146B1
(en)
|
1991-03-11 |
2001-04-03 |
Curis, Inc. |
60A protein-induced morphogenesis
|
|
US5460964A
(en)
*
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
|
US5436151A
(en)
*
|
1992-04-03 |
1995-07-25 |
Regents Of The University Of Minnesota |
Method for culturing human hematopoietic stem cells in vitro
|
|
IL110195A
(en)
*
|
1994-07-03 |
2003-10-31 |
David Danon |
Method and system for cultivating macrophages
|
|
US6498142B1
(en)
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
|
ATE278414T1
(de)
|
1997-05-05 |
2004-10-15 |
Curis Inc |
Therapien zur behandlung von akutem nierenversagen
|
|
US8435939B2
(en)
*
|
2000-09-05 |
2013-05-07 |
Biokine Therapeutics Ltd. |
Polypeptide anti-HIV agent containing the same
|
|
EP1541585B1
(en)
|
2002-08-27 |
2013-01-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist and use thereof
|
|
US8029985B2
(en)
*
|
2004-09-01 |
2011-10-04 |
Vybion, Inc. |
Amplified bioassay
|
|
CA2673719C
(en)
*
|
2006-12-21 |
2018-07-24 |
Biokine Therapeutics Ltd. |
T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery
|
|
EP2396023A2
(en)
|
2009-02-11 |
2011-12-21 |
Yeda Research and Development Co. Ltd. |
Short beta-defensin-derived peptides
|
|
EP2442822B1
(en)
|
2009-06-14 |
2014-03-05 |
Biokine Therapeutics Ltd. |
Peptide therapy for increasing platelet levels
|
|
WO2013160895A1
(en)
|
2012-04-24 |
2013-10-31 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
|
CN116196426A
(zh)
|
2015-07-16 |
2023-06-02 |
百欧肯治疗有限公司 |
治疗癌症的组合物及方法
|
|
AU2017222495B2
(en)
|
2016-02-23 |
2019-08-08 |
Biolinerx Ltd. |
Methods of treating acute myeloid leukemia
|